CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions |
12 Months Ended |
Feb. 01, 2020 |
Feb. 02, 2019 |
Feb. 03, 2018 |
| Cash flows from operating activities |
|
|
|
|
| Net income/(loss) |
|
$ (268)
|
$ (255)
|
$ (118)
|
| Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities: |
|
|
|
|
| Restructuring and management transition |
|
23
|
(3)
|
74
|
| Asset impairments and other charges |
|
0
|
56
|
6
|
| Net gain on sale of non-operating assets |
|
(1)
|
0
|
0
|
| Net gain from sale of operating assets |
|
(8)
|
(67)
|
(119)
|
| (Gain)/loss on extinguishment of debt |
|
(1)
|
23
|
33
|
| Depreciation and amortization |
|
544
|
556
|
570
|
| Benefit plans |
|
(37)
|
(65)
|
106
|
| Stock-based compensation |
[1] |
11
|
10
|
25
|
| Other comprehensive income tax benefits |
|
0
|
(11)
|
(60)
|
| Deferred taxes |
|
(6)
|
(13)
|
(63)
|
| Change in cash from: |
|
|
|
|
| Inventory |
|
271
|
366
|
93
|
| Prepaid expenses and other assets |
|
(9)
|
1
|
(15)
|
| Merchandise accounts payable |
|
(61)
|
(126)
|
(4)
|
| Income taxes |
|
0
|
0
|
(12)
|
| Accrued expenses and other |
|
(30)
|
(113)
|
(62)
|
| Net cash provided by/(used in) operating activities |
|
428
|
359
|
454
|
| Cash flows from investing activities |
|
|
|
|
| Capital expenditures |
|
(309)
|
(392)
|
(395)
|
| Proceeds from sale of non-operating assets |
|
1
|
0
|
0
|
| Proceeds from sale of operating assets |
|
26
|
144
|
154
|
| Joint venture return of investment |
|
0
|
3
|
9
|
| Insurance proceeds received for damage to property and equipment |
|
6
|
1
|
3
|
| Net cash provided by/(used in) investing activities |
|
(276)
|
(244)
|
(229)
|
| Cash flows from financing activities |
|
|
|
|
| Proceeds from issuance of long-term debt |
|
0
|
400
|
0
|
| Proceeds from borrowings under the credit facility |
|
2,645
|
3,895
|
804
|
| Payments of borrowings under the credit facility |
|
(2,645)
|
(3,895)
|
(804)
|
| Premium on early retirement of debt |
|
0
|
(20)
|
(30)
|
| Payments of finance leases and note payable |
|
(3)
|
(6)
|
(16)
|
| Payments of long-term debt |
|
(97)
|
(607)
|
(599)
|
| Financing costs |
|
0
|
(7)
|
(9)
|
| Proceeds from stock issued under stock plans |
|
2
|
3
|
5
|
| Tax withholding payments for vested restricted stock |
|
(1)
|
(3)
|
(5)
|
| Net cash provided by/(used in) financing activities |
|
(99)
|
(240)
|
(654)
|
| Net increase/(decrease) in cash and cash equivalents |
|
53
|
(125)
|
(429)
|
| Cash and cash equivalents at beginning of period |
|
333
|
458
|
887
|
| Cash and cash equivalents at end of period |
|
$ 386
|
$ 333
|
$ 458
|
|
|